Nanobacterie Overview

  • Founded
  • 2008
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Nanobacterie General Information


Developer of a magnetic nanoparticles based treatment therapy designed to treat cancerous tumors. The company's therapy uses nanoparticles containing iron oxide, which are introduced into solid tumors and then subjected to an alternating magnetic field, enabling doctors to dissolve tumor tissue through this therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Batiment 201
  • Université Paris-Sud
  • 91405 Orsay
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobacterie Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Nanobacterie’s complete valuation and funding history, request access »

Nanobacterie Executive Team (1)

Name Title Board Seat Contact Info
Laurence Rivain Founder
To view Nanobacterie’s complete executive team members history, request access »

Nanobacterie Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Nanobacterie’s complete investors history, request access »